Nardostachys jatamansi Extract and Nardosinone Exert Neuroprotective Effects by Suppressing Glucose Metabolic Reprogramming and Modulating T Cell Infiltration
Open Access
Abstract
Background: Nardostachys jatamansi DC. (Gansong), a widely utilized herb in traditional Chinese medicine, has been historically employed in the management of various neuropsychiatric disorders. Nardosinone (Nar), a sesquiterpenoid compound, has been identified as one of the principal bioactive constituents of N. jatamansi. This study investigated the effects of ethyl acetate extract (NJ-1A) from N. jatamansi and its active constituent nardosinone on neuroinflammatory mediator release, glucose metabolic reprogramming, and T cell migration using both in vitro and in vivo experimental models. Methods: Lipopolysaccharide(LPS)-induced BV-2 microglial cells and a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid (MPTP/p)-induced male C57BL/6N mouse chronic model of Parkinson’s disease were applied. Results: Both NJ-1A and Nar could significantly suppress LPS-induced production of M1 pro-inflammatory factors or markers in microglia and could inhibit the glycolytic process and promote oxidative phosphorylation via the AKT/mTOR signaling pathway. Furthermore, they exhibited the capacity to attenuate chemokine release from activated microglia, consequently reducing T cell migration. In vivo experiments revealed that NJ-1A and Nar effectively inhibited microglial activation, diminished T cell infiltration, and mitigated the loss of tyrosine hydroxylase (TH)-positive dopaminergic neurons in the substantia nigra of MPTP-induced mice. Conclusions: NJ-1A and nardosinone exert neuroprotective effects through the modulation of microglial polarization states, regulation of metabolic reprogramming, and suppression of T cell infiltration.Keywords
Funding Information
- National Natural Science Foundation of China (82274135, 202310063036)
- Tianjin University of Traditional Chinese Medicine College Student Science and Technology Innovation Fund Project (82274135, 202310063036)
This publication has 58 references indexed in Scilit:
- Exploring the role of T cells in Alzheimer's and other neurodegenerative diseases: Emerging therapeutic insights from the T Cells in the Brain symposiumAlzheimer's & Dementia, 2025
- Target modulation of glycolytic pathways as a new strategy for the treatment of neuroinflammatory diseasesAgeing Research Reviews, 2024
- Th1/Th2 Imbalance in Peripheral Blood Echoes Microglia State Dynamics in CNS During TLE ProgressionAdvanced Science, 2024
- Oxidative stress and regulated cell death in Parkinson’s diseaseAgeing Research Reviews, 2021
- Molecular Regulatory Mechanism and Toxicology of Neurodegenerative Processes in MPTP/Probenecid-Induced Progressive Parkinson’s Disease Mice Model Revealed by TranscriptomeMolecular Neurobiology, 2020
- Cerebral dopamine neurotrophic factor protects microglia by combining with AKT and by regulating FoxO1/mTOR signaling during neuroinflammationBiomedicine & Pharmacotherapy, 2019
- Metabolic reprogramming of mitochondrial respiration in metastatic cancerCancer and Metastasis Reviews, 2018
- Microglia-Mediated Inflammation and Neurodegenerative DiseaseMolecular Neurobiology, 2015
- Differential Roles of M1 and M2 Microglia in Neurodegenerative DiseasesMolecular Neurobiology, 2015
- Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brainsActa Neuropathologica, 2003